HomeCompareCBLEQ vs JNJ

CBLEQ vs JNJ: Dividend Comparison 2026

CBLEQ yields 723.17% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CBLEQ wins by $1190199.85M in total portfolio value
10 years
CBLEQ
CBLEQ
● Live price
723.17%
Share price
$1.60
Annual div
$11.57
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1190199.88M
Annual income
$935,679,320,699.94
Full CBLEQ calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — CBLEQ vs JNJ

📍 CBLEQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCBLEQJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CBLEQ + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CBLEQ pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CBLEQ
Annual income on $10K today (after 15% tax)
$61,469.67/yr
After 10yr DRIP, annual income (after tax)
$795,327,422,594.95/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, CBLEQ beats the other by $795,327,418,608.96/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CBLEQ + JNJ for your $10,000?

CBLEQ: 50%JNJ: 50%
100% JNJ50/50100% CBLEQ
Portfolio after 10yr
$595099.95M
Annual income
$467,839,662,694.67/yr
Blended yield
78.62%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CBLEQ
Analyst Ratings
1
Hold
3
Sell
Consensus: Sell
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CBLEQ buys
0
JNJ buys
0
No recent congressional trades found for CBLEQ or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCBLEQJNJ
Forward yield723.17%2.13%
Annual dividend / share$11.57$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$1190199.88M$30.3K
Annual income after 10y$935,679,320,699.94$4,689.40
Total dividends collected$1169714.58M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusSellBuy

Year-by-year: CBLEQ vs JNJ ($10,000, DRIP)

YearCBLEQ PortfolioCBLEQ Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$83,017$72,317.26$10,592$272.30+$72.4KCBLEQ
2$649,911$561,082.26$11,289$357.73+$638.6KCBLEQ
3$4,800,546$4,105,141.10$12,123$472.89+$4.79MCBLEQ
4$33,475,367$28,338,783.58$13,141$629.86+$33.46MCBLEQ
5$220,503,880$184,685,237.09$14,408$846.81+$220.49MCBLEQ
6$1,372,883,712$1,136,944,560.12$16,021$1,151.60+$1372.87MCBLEQ
7$8,084,643,279$6,615,657,707.69$18,122$1,588.22+$8084.63MCBLEQ
8$45,060,206,127$36,409,637,817.54$20,930$2,228.20+$45060.19MCBLEQ
9$237,869,680,933$189,655,260,377.37$24,792$3,191.91+$237869.66MCBLEQ
10$1,190,199,879,298$935,679,320,699.94$30,274$4,689.40+$1190199.85MCBLEQ

CBLEQ vs JNJ: Complete Analysis 2026

CBLEQStock

Headquartered in Chattanooga, TN, CBL Properties owns and manages a national portfolio of market-dominant properties located in dynamic and growing communities. CBL's portfolio is comprised of 107 properties totaling 66.7 million square feet across 26 states, including 65 high quality enclosed, outlet and open-air retail centers and 8 properties managed for third parties. CBL seeks to continuously strengthen its company and portfolio through active management, aggressive leasing and profitable reinvestment in its properties. On November 1, 2020, CBL & Associates Properties, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas.

Full CBLEQ Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this CBLEQ vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CBLEQ vs SCHDCBLEQ vs JEPICBLEQ vs OCBLEQ vs KOCBLEQ vs MAINCBLEQ vs ABBVCBLEQ vs MRKCBLEQ vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.